Fin|Tech|Bio: The Future of Data and Cross-Sector Synergies
Fin|Tech|Bio returns to Level39, in partnership with Canary Wharf Group Life Sciences, with another anticipated sell-out evening exploring the ideas, partnerships and technologies shaping the future at the intersection of finance, technology, life sciences and healthcare.
Data is redefining innovation across sectors. Whether enabling personalised medicine or powering precision finance, access to high-quality, trusted and ethical data is becoming critical to progress.
But unlocking its full potential requires collaboration across industries, new approaches to governance, and technologies that enable secure and responsible data sharing.
This event brings together leaders from FinTech, Health and Life Sciences to explore how cross-sector data ecosystems are creating new value streams, accelerating breakthroughs and improving outcomes.
With opening remarks from Level39 and Canary Wharf Group, the evening will feature a panel discussion followed by audience Q&A and networking with a highly engaged audience of founders, operators, investors and ecosystem leaders.
We’re also pleased to welcome Mike McMillan (CPRD), who will showcase the launch of CPRD Emulate, CPRD’s new synthetic data platform and MHRA government cost recovery service, demonstrating how synthetic health data can enable secure, privacy-first innovation.
Speakers
Mike McMillan – Head of Business Development, Clinical Practice Research Datalink (CPRD)
Mike has nearly 40 years’ experience in UK health data, spanning public and private sector roles. At CPRD, the UK’s leading source of real-world health data, he focuses on developing innovative solutions including CPRD Emulate, a self-service synthetic tabular data generator for near real-time research.
Catriona Campbell - Author | Speaker | Chair I AI 100, UK
Catriona is a technologist and author with 20+ years in digital transformation and responsible AI. Best-selling author of AI by Design, she chairs the Scottish AI Alliance and has been awarded an MBE for services to technology and innovation.
Michael Cook - Chief Science Officer, Our Future Health UK
Michael brings deep expertise in molecular and epidemiological sciences. Formerly a Senior Investigator at the US National Cancer Institute (NIH), he now drives large-scale population health studies, including the world’s largest prospective cohort with biobanked blood samples.
Adi Ben-Ari - Founder & CEO, Applied Blockchain
Founder and CEO of Applied Blockchain with over 20 years’ enterprise software experience, Adi is a recognised blockchain and cryptography thought leader, government advisor, and co-inventor of multiple patents in data privacy and confidential computing.
John Baker - CEO, IMU Biosciences
Leads IMU Biosciences in AI-driven immune profiling for precision medicine. Previously on Abcam’s Executive Team during its global growth and $5.7B Danaher acquisition, he is a Cambridge-trained veterinarian with an Oxford DPhil and extensive biotech leadership experience.
Key themes
Data as a catalyst How shared data ecosystems can unlock innovation and competitive advantage
Cross-sector synergies
Real-world opportunities and examples of successful collaboration across finance, healthcare and life sciences
Governance & compliance Navigating regulation, ethics and trust in data sharing
Emerging technologies The role of AI, blockchain and secure data platforms in enabling trusted partnerships
Event format
5:30pm – 6:10pm Arrival & Networking
6:10pm – 6:15pm
Welcome & Opening Remarks
Level39 & Canary Wharf Group
6:15pm – 6:25pm
CPRD Emulate Showcase Mike McMillan, Business Development Team Leader, CPRD
6:25pm – 7:15pm
Panel Discussion & Audience Q&A
7:15pm - 8:00pm
Closing Remarks & Networking
Fin|Tech|Bio events consistently sell out - early registration is strongly recommended.